Additional file 3: of Safety and efficacy of fruquintinib in patients with previously treated metastatic colorectal cancer: a phase Ib study and a randomized double-blind phase II study

Xu, Rui-Hua; Li, Jin; Bai, Yuxian; Xu, Jianming; Liu, Tianshu; Shen, Lin; Wang, Liwei; Pan, Hongming; Cao, Junning; Zhang, Dongsheng; Fan, Songhua; Hua, Ye; Su, Weiguo

doi:10.6084/m9.figshare.c.3670036_D4.v1

13045_2016_384_MOESM3_ESM.pdf (104.48 kB)

Additional file 3: of Safety and efficacy of fruquintinib in patients with previously treated metastatic colorectal cancer: a phase Ib study and a randomized double-blind phase II study

journal contribution

posted on 2017-01-19, 05:00 authored by Rui-Hua Xu, Jin Li, Yuxian Bai, Jianming Xu, Tianshu Liu, Lin Shen, Liwei Wang, Hongming Pan, Junning Cao, Dongsheng Zhang, Songhua Fan, Ye Hua, Weiguo Su

Forest plot of subgroup analysis in phase II study. (PDF 104 kb)

History

Usage metrics

Keywords

Fruquintinib Metastatic colorectal cancer Progression-free survival VEGFR

Licence

CC BY + CC0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

Additional file 3: of Safety and efficacy of fruquintinib in patients with previously treated metastatic colorectal cancer: a phase Ib study and a randomized double-blind phase II study

History

Usage metrics

Categories

Keywords

Licence

Exports